Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-07

Clinical Trial Update: ALDH2 Single Nucleotide Polymorphisms and Prognosis of Esophageal Cancer Patients

View source ↗

Summary

A clinical trial investigating ALDH2 gene polymorphisms and prognosis in esophageal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Esophageal Cancer | Status: RECRUITING